123 related articles for article (PubMed ID: 18316983)
1. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection.
Quillen K; Lane C; Hu E; Pelton S; Bateman S
Pediatr Infect Dis J; 2008 Apr; 27(4):357-8. PubMed ID: 18316983
[TBL] [Abstract][Full Text] [Related]
2. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
3. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone-induced immune hemolytic anemia.
Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
Moallem HJ; Garratty G; Wakeham M; Dial S; Oligario A; Gondi A; Rao SP; Fikrig S
J Pediatr; 1998 Aug; 133(2):279-81. PubMed ID: 9709722
[TBL] [Abstract][Full Text] [Related]
6. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry.
Kakaiya R; Cseri J; Smith S; Silberman S; Rubinas TC; Hoffstadter A
Arch Pathol Lab Med; 2004 Aug; 128(8):905-7. PubMed ID: 15270609
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
[TBL] [Abstract][Full Text] [Related]
8. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
Dinesh D; Dugan N; Carter J
Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC disease.
Van Buren NL; Gorlin JB; Reed RC; Gottschall JL; Nelson SC
Transfusion; 2018 Apr; 58(4):879-883. PubMed ID: 29473172
[TBL] [Abstract][Full Text] [Related]
10. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
[TBL] [Abstract][Full Text] [Related]
11. Severe hemolytic crisis after ceftriaxone administration.
Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
[TBL] [Abstract][Full Text] [Related]
12. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
Corso M; Ravindranath TM
Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
[TBL] [Abstract][Full Text] [Related]
13. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
[TBL] [Abstract][Full Text] [Related]
14. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
Garratty G; Postoway N; Schwellenbach J; McMahill PC
Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease.
Al-Mendalawi MD
Saudi Med J; 2011 Mar; 32(3):320. PubMed ID: 21384076
[No Abstract] [Full Text] [Related]
16. Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease.
Al-Hawsawi ZM; Turkistani WA; Al-Aidaros MA; Al-Harbi DL
Saudi Med J; 2010 Jul; 31(7):826-8. PubMed ID: 20635020
[TBL] [Abstract][Full Text] [Related]
17. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC
Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608
[TBL] [Abstract][Full Text] [Related]
18. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
[No Abstract] [Full Text] [Related]
19. [Infection in sickle cell disease].
Lesprit E; Lesprit P
Rev Prat; 2004 Sep; 54(14):1574-7. PubMed ID: 15558970
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to red blood cell antigens occur frequently with hemolysis among pediatric small bowel transplant recipients: clinical implications and management.
Koepsell SA; Grant W; Landmark JD
Pediatr Transplant; 2015 Feb; 19(1):62-7. PubMed ID: 25400072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
